Showing results (71-80 of 499) with videos related to
Sort By:
Pageof 50
Cellular and Molecular Life Sciences : CMLS|April 14, 2017
Ceramide synthase 2 deficiency aggravates AOM-DSS-induced colitis in mice: role of colon barrier integrityStephanie Oertel, Klaus Scholich, Andreas Weigert, et al.Free Radical Biology & Medicine|September 20, 2022
Cold avoidance and heat pain hypersensitivity in neuronal nucleoredoxin knockout miceLucie Valek, Bao Ngoc Tran, Irmgard TegederBritish Journal of Pharmacology|October 15, 2010
Pharmacogenetics of new analgesicsJörn Lötsch, Gerd GeisslingerExpert Review of Proteomics|April 12, 2013
Proteomics and NF-κB: an updateEllen Niederberger, Gerd GeisslingerTrends in Pharmacological Sciences|July 4, 2006
Is mPGES-1 a promising target for pain therapy?Klaus Scholich, Gerd GeisslingerDrug Discovery Today|October 22, 2011
Low-dose drug combinations along molecular pathways could maximize therapeutic effectiveness while minimizing collateral adverse effectsJörn Lötsch, Gerd GeisslingerTrends in Pharmacological Sciences|May 21, 2010
A critical appraisal of human genotyping for pain therapyJörn Lötsch, Gerd GeisslingerTrends in Pharmacological Sciences|January 27, 2023
Rethinking the use of NSAIDs in early acute painMarco Sisignano, Gerd GeisslingerAnesthesiology|January 24, 2008
Proteomics in neuropathic pain researchEllen Niederberger, Gerd GeisslingerTrends in Molecular Medicine|February 8, 2005
Are mu-opioid receptor polymorphisms important for clinical opioid therapy?Jörn Lötsch, Gerd GeisslingerPageof 50